Flora Growth (Flora Growth) FCF Margin % : -6.48% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Flora Growth FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Flora Growth's Free Cash Flow for the three months ended in Dec. 2023 was $-1.16 Mil. Flora Growth's Revenue for the three months ended in Dec. 2023 was $17.98 Mil. Therefore, Flora Growth's FCF Margin % for the quarter that ended in Dec. 2023 was -6.48%.

As of today, Flora Growth's current FCF Yield % is -49.15%.

The historical rank and industry rank for Flora Growth's FCF Margin % or its related term are showing as below:

FLGC' s FCF Margin % Range Over the Past 10 Years
Min: -8165.09 Med: -164.56 Max: -11.23
Current: -11.23

During the past 5 years, the highest FCF Margin % of Flora Growth was -11.23%. The lowest was -8165.09%. And the median was -164.56%.

FLGC's FCF Margin % is ranked worse than
69.13% of 1027 companies
in the Drug Manufacturers industry
Industry Median: -0.42 vs FLGC: -11.23

Flora Growth FCF Margin % Historical Data

The historical data trend for Flora Growth's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Flora Growth FCF Margin % Chart

Flora Growth Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

-8,165.09

-277.53

-51.58

-11.34

Flora Growth Quarterly Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial										-12.40	-22.01	-16.55	2.96	-6.48

Competitive Comparison of Flora Growth's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Flora Growth's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Flora Growth's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Flora Growth's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Flora Growth's FCF Margin % falls into.

Flora Growth FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Flora Growth's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-8.63	/	76.071
	=	-11.34 %

Flora Growth's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-1.164	/	17.975
	=	-6.48 %

Flora Growth FCF Margin % Related Terms

Thank you for viewing the detailed overview of Flora Growth's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Flora Growth (Flora Growth) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Flora Growth Corp (NAS:FLGC) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

3406 South West 26th Terrace, Suite C-1, Fort Lauderdale, FL, USA, 33132

Website

https://www.floragrowth.com

Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company operates in the United States, Germany, Colombia, the United Kingdom, and Canada. it derives a majority of its revenue from the United States.

Executives

Thomas Solomon	director	C/O FLORA GROWTH CORP., 365 BAY STREET; SUITE 800, TORONTO Z4 M5H 2V1
Kevin Taylor	director	C/O COOL HOLDINGS, INC., 2001 NW 84TH AVENUE, MIAMI FL 33122
Hussein Rakine	director, officer: Chief Executive Officer	5258 SW 183RD AVENUE, MIRAMAR FL 33029
Clifford Starke	director, officer: President	C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Edward Woo	director	C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
John Timothy Leslie	director	C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Marc Mastronardi	director	C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Jason Warnock	officer: CCO	C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Annabella Manalo Morgan	director	C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Jessie Casner	officer: CMO	C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Dany Vaiman	officer: Sr. VP Finance	C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Elshad Garayev	officer: CFO	C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Beverley Richardson	director	C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Roa Juan Carlos Gomez	director	C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Luis Merchan	director, officer: CEO & Chairman of the Board	C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312